Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FRBW1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,630
Award facts
- Contract value 100% obligated
- $10,629.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,629.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The contract was awarded on December 10, 2025, with an ultimate completion date of January 2, 2026, under firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier for the Department of Defense's global military healthcare operations under the broader $30.3 billion PPV-G GEN V acquisition strategy. The company's established performance across numerous delivery orders demonstrates its capability to fulfill diverse pharmaceutical requirements, including branded and generic prescription medications, biologics, vaccines, and specialty medical consumables. The underlying IDC contract represents a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as one of multiple prime vendors authorized to supply pharmaceutical products to military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FRBW1?
SPE2DR26FRBW1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FRBW1 worth?
The government has obligated $10,630 on SPE2DR26FRBW1.
Is contract SPE2DR26FRBW1 an order under another contract?
Yes. SPE2DR26FRBW1 is a delivery order under SPE2DR25D9206, an indefinite delivery contract.
Was contract SPE2DR26FRBW1 competed?
The extent of competition for SPE2DR26FRBW1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award